Core Points - Trading in Charming Medical Limited (Nasdaq: MCTA) has been halted by Nasdaq for additional information requested from the company [1] - The Securities and Exchange Commission (SEC) previously suspended trading in MCTA from November 12, 2025, to November 25, 2025 [1] - The last sale price of MCTA's ordinary shares was $29.355 [1] Summary by Sections - **Trading Suspension** - Nasdaq has halted trading in Charming Medical Limited for further information [1] - SEC's trading suspension lasted from 04:00 on November 12, 2025, to 23:59 on November 25, 2025 [1] - **Company Information** - Trading will remain halted until the company fully satisfies Nasdaq's request for additional information [2] - For further news and information, stakeholders are advised to contact the company directly or check under the company's symbol on the Nasdaq website [2]

Core Insights - Chinese concept stocks experienced significant gains, with notable increases in share prices for several companies [1] Group 1: Stock Performance - Haitan Network (HKIT) saw a remarkable increase of 89.5%, closing at 4.150, with a trading volume of 30.9931 million [1] - Kuke Music (KUKEY) rose by 54.46%, reaching a price of 0.3500, with a trading volume of 4.59356 million [1] - Masonglory (MSGY) increased by 53.68%, closing at 1.4600, with a trading volume of 36.3651 million [1] - Rongzhi Group (SUGP) experienced a gain of 29.1%, closing at 7.010, with a trading volume of 570,800 [1] - Meiyantang (MCTA) rose by 24.43%, closing at 27.500, with a trading volume of 4.553 million [1]

Core Viewpoint - Chinese concept stocks experienced significant gains, with notable increases in share prices for several companies, indicating a positive market sentiment towards these stocks [1] Group 1: Stock Performance - Kuke Music (KUKEY) saw a remarkable increase of 120%, closing at 0.1100, with a trading volume of 4,794.6 thousand [1] - BQ (波奇宠物) rose by 113.73%, closing at 16.970, with a trading volume of 6,299.85 thousand [1] - Meiyantang (美妍堂) increased by 45.04%, closing at 27.760, with a trading volume of 1,703.51 thousand [1] - Advanced Biomed (ADVB) experienced a rise of 24.56%, closing at 0.5671, with a trading volume of 1,576.66 thousand [1] - Blue Mountain Holdings (BMHL) gained 22.80%, closing at 3.770, with a trading volume of 3.75 thousand [1]

Group 1 - The top five gainers among Chinese concept stocks include Kuke Music with a rise of 263.64%, Meiyantang with 34.69%, Wangsu Technology with 33.89%, Jian Yong Biotechnology with 24.46%, and Haodingduo with 13.47% [1] - Kuke Music's latest price is 0.0500, with a gain of 0.0363 and a trading volume of 1840.56 thousand [1] - Meiyantang's latest price is 19.140, with a gain of 4.930 and a trading volume of 10.7747 million [1] - Wangsu Technology's latest price is 8.770, with a gain of 2.220 and a trading volume of 2.6759 million [1] - Jian Yong Biotechnology's latest price is 50.020, with a gain of 9.830 and a trading volume of 10.2408 million [1] - Haodingduo's latest price is 3.960, with a gain of 0.470 and a trading volume of 10.7239 million [1]

Group 1 - The top five gaining Chinese concept stocks at closing were: Meiyan Tang up 46.95%, Xingji Fashion up 34.47%, 707 Cayman Holdings up 27.28%, Quhuo up 25.5%, and J-Star Holding up 22.36% [1] - Meiyan Tang (MCTA) closed at 14.210 with a gain of 46.95%, increasing by 4.540, and had a trading volume of 12.77 million [1] - Xingji Fashion (STFS) closed at 0.2138 with a gain of 34.47%, increasing by 0.0548, and had a trading volume of 6.29 million [1] - 707 Cayman Holdings (JEM) closed at 0.3761 with a gain of 27.28%, increasing by 0.0806, and had a trading volume of 19.21 million [1] - Quhuo (QH) closed at 8.120 with a gain of 25.5%, increasing by 1.650, and had a trading volume of 2.68 million [1] - J-Star Holding (YMAT) closed at 1.0500 with a gain of 22.36%, increasing by 0.1919, and had a trading volume of 37.19 million [1]

Core Viewpoint - Charming Medical Limited, a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies, has successfully completed its initial public offering (IPO) and has raised approximately $7.36 million in gross proceeds from the offering, including an over-allotment option exercised by underwriters [1][2]. Company Overview - Charming Medical Limited integrates TCM principles with modern technology to enhance quality of life and promote holistic well-being. The company operates four wellness centers in Hong Kong, offering services such as womb-warming therapy, pelvic detox therapy, moxibustion, prenatal massage, and traditional abdominal binding, focusing on women's health issues [6]. - Under the "Beauty Lab" brand, the company develops and distributes TCM-inspired supplements and beauty products aimed at improving women's constitution and vitality. These products include uterine care patches, probiotic washes, and nourishing herbal formulations [6]. - The company also provides technical training, dietary therapy consultancy, and franchise opportunities to extend its wellness philosophy to other practitioners and entrepreneurs [6]. Offering Details - The IPO consisted of 1,600,000 Class A ordinary shares priced at $4.00 per share, with an additional 240,000 shares purchased through the over-allotment option, resulting in gross proceeds of $0.96 million from the over-allotment [1][2]. - The offering was conducted on a firm commitment basis, with Cathay Securities, Inc. acting as the representative of the underwriters [3]. - The registration statement for the offering was filed with the SEC and declared effective on September 30, 2025, with a final prospectus available on the SEC's website [4].

Core Viewpoint - Chinese concept stocks experienced significant gains, with the top five performers showing substantial percentage increases in their stock prices [1] Group 1: Top Gainers - Meiyan Tang (MCTA) saw a price increase of 30.5%, closing at 9.670, with a trading volume of 3.2172 million [1] - Wangsu Technology (NPT) rose by 29.47%, closing at 6.370, with a trading volume of 3.7132 million [1] - Xiangsong International (CHSN) increased by 19.64%, closing at 2.500, with a trading volume of 292.2 thousand [1] - ChowChow Cloud International (CHOW) gained 15.83%, closing at 9.220, with a trading volume of 4.1036 million [1] - Meihua International (MHUA) rose by 15.05%, closing at 0.2561, with a trading volume of 250.6 thousand [1]

Core Viewpoint - Charming Medical Limited has successfully completed its initial public offering (IPO) on the Nasdaq Capital Market, raising a total of $6.4 million from the sale of 1,600,000 Class A ordinary shares at a price of $4.00 per share [1][2]. Group 1: Offering Details - The IPO consisted of 1,600,000 Class A ordinary shares priced at $4.00 each, with trading commencing on October 21, 2025 [1]. - The total gross proceeds from the offering amount to $6.4 million, which will be utilized for business expansion, strategic investments, research and development, and general corporate purposes [2]. - An over-allotment option has been granted to underwriters for an additional 240,000 shares, which could increase gross proceeds to approximately $7.36 million if fully exercised [3]. Group 2: Company Background - Charming Medical Limited is a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, integrating TCM principles with modern technology [7]. - The company operates four wellness centers in Hong Kong, offering services aimed at addressing women's health issues, including womb-warming therapy and prenatal massage [7]. - Under the "Beauty Lab" brand, the company develops TCM-inspired supplements and beauty products, focusing on improving women's health and vitality [7].

Core Viewpoint - Beauty Lab (MCTA.US), a Hong Kong-based traditional Chinese medicine (TCM) company, successfully launched its IPO on NASDAQ, pricing shares at $4 each, raising $6 million, and saw a 75% increase on its first trading day closing at $7.0 [1] Company Overview - Beauty Lab is headquartered in Hong Kong and offers TCM-inspired therapies and products [1] - The company operates four health centers under the "Beauty Lab" brand in Hong Kong, providing beauty, health, and postpartum services and products [1] - Beauty Lab also offers customized TCM therapies for men [1] Financial Performance - For the six months ending September 30, 2024, Beauty Lab reported revenues of $2.96 million, up from $2.61 million in the same period last year [1] - The net profit for the same period increased to $470,000 from $380,000 year-on-year [1]

Core Insights - Charming Medical Ltd (美妍堂) successfully listed on NASDAQ under the ticker MCTA on October 21, 2025, raising $6.4 million by issuing 160,000 shares at an initial price of $4 per share [3][10]. Company Overview - Charming Medical Ltd is a Hong Kong-based company focused on Traditional Chinese Medicine (TCM) inspired therapies and products, operating four health therapy centers in Hong Kong [4]. - The company offers a range of services including warming therapy, pelvic detox therapy, moxibustion, prenatal massage, and traditional binding to address women's health issues related to hormonal imbalances and postpartum recovery [4]. - Under the "Beauty Lab" brand, the company develops and sells TCM-inspired dietary supplements and beauty products aimed at improving women's health and vitality [4]. Financial Information - On its first trading day, MCTA closed at $7.00, marking a 75% increase from its IPO price, with a market capitalization of approximately $119 million [10][12]. - The stock experienced a trading volume of 4.2187 million shares, with a price range during the day between $4.30 and $8.21 [12]. Management and Directors - Kit Wong serves as the Director, CEO, and Chairman of the Board, bringing extensive experience in postpartum repair and TCM-inspired health maintenance [7]. - Ching Man Cheung, the Chief Financial Officer, has nearly 20 years of experience in accounting and financial management, overseeing all financial aspects of the company [8]. - The board includes independent directors with diverse backgrounds in finance and TCM, enhancing the company's governance and strategic direction [9].